SUN PHARM Company Profile

✉ Email this page to a colleague

SUN PHARM has five hundred and forty-eight approved drugs.

There are thirty-three US patents protecting SUN PHARM drugs. There are eighteen tentative approvals on SUN PHARM drugs.

There are three hundred and seventy-nine patent family members on SUN PHARM drugs in fifty-eight countries and six hundred and nineteen supplementary protection certificates in nineteen countries.

International Patents:	379
US Patents:	33
Tradenames:	354
Ingredients:	328
NDAs:	548
Patent Litigation for SUN PHARM:	See patent lawsuits for SUN PHARM
PTAB Cases with SUN PHARM as petitioner:	See PTAB cases with SUN PHARM as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	203059-002	Sep 9, 2013		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Ltd	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	091118-004	Sep 25, 2014		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Inc	CLONAZEPAM	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	078654-004	Aug 27, 2014	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Industries	CARVEDILOL PHOSPHATE	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	090132-001	Oct 25, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Industries	DOXYCYCLINE HYCLATE	doxycycline hyclate	CAPSULE;ORAL	062676-002	Jul 10, 1986	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm	DEFERASIROX	deferasirox	TABLET, FOR SUSPENSION;ORAL	209782-002	Nov 20, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Inc	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	CAPSULE;ORAL	090651-001	Apr 7, 2014		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Industries	BACTRIM DS	sulfamethoxazole; trimethoprim	TABLET;ORAL	017377-002	Approved Prior to Jan 1, 1982	RE28636	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-006	Aug 15, 2014	9,078,925	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-006	Aug 15, 2014	8,952,064	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-002	May 25, 2012	9,078,925	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-002	May 25, 2012	8,367,102	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-001	May 25, 2012	8,952,064	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-006	Aug 15, 2014	9,089,534	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Capsules	30 mg and 40 mg	➤ Subscribe	2012-12-31
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-06-19
➤ Subscribe	Capsules	25 mg	➤ Subscribe	2016-05-16
➤ Subscribe	Tablets	125 mg	➤ Subscribe	2018-07-23
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-01-07
➤ Subscribe	Capsules	35 mg	➤ Subscribe	2015-11-25

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016051288	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2010102192	⤷ Try a Trial
Canada	2736751	⤷ Try a Trial
South Korea	101832041	⤷ Try a Trial
South Korea	101495192	⤷ Try a Trial
Japan	2023103410	⤷ Try a Trial
Canada	2907415	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0720599	CR 2014 00050	Denmark	⤷ Try a Trial	PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910
2316456	132017000142109	Italy	⤷ Try a Trial	PRODUCT NAME: NALTREXONE/BUPROPIONE(MYSIMBA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/988, 20150330
0933372	PA2008006,C0933372	Lithuania	⤷ Try a Trial	PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
1539166	2013C/064	Belgium	⤷ Try a Trial	PRODUCT NAME: DEXTROMETHORPHANE OU UN SEL, PRCURSEUR DE DERIVE PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE BROMHYDRURE DE DEXTROMETORPHANE ET EN PARTICULIER LE BROMHYDRURE DE DEXTROMETROPHANE MONHYDRATE ET QUINIDINE OU UN SEL,....; AUTHORISATION NUMBER AND DATE: EU/1/13/833 20130626
0428296	SPC/GB98/013	United Kingdom	⤷ Try a Trial	PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
1261586	C300524	Netherlands	⤷ Try a Trial	PRODUCT NAME: COMBINATIE VAN SAXAGLIPTINE EN METFORMINE, DESGEWENST IN DE VORM VAN FARMACEUTISCH AANVAARDBARE AFGELEIDEN DAARVAN; NAT. REGISTRATION NO/DATE: EU/1/11/731/001-012 20111124; FIRST REGISTRATION:
2021328	658	Finland	⤷ Try a Trial
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.